Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
docetaxel (taxotere) (1 trial)
hyaluronidase (human recombinant) (Hylenex) (1 trial)
mitomycin (mutamycin) (1 trial)
Carcinoma (Phase 2)
Carcinoma, Transitional Cell (Phase 2)
Neoplasms (Phase 2)
Urinary Bladder Neoplasms (Phase 2)
Urogenital Neoplasms (Phase 2)
Urologic Neoplasms (Phase 2)
Trials (2 total)
Trial APIs (3 total)